CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, and Adaptiiv (formerly 3D Bolus), the definitive 3D technology platform for radiation therapy, are excited to announce their collaboration in bringing more personalized medical devices to the market.
McCain Foods Limited has completed a strategic investment in TruLeaf Sustainable Agriculture, a highly innovative Canadian agricultural technology company. TruLeaf has developed proprietary indoor vertical farming technology to grow fresh and nutritious leafy greens of high quality and flavour, in an environmentally sustainable way, 365 days per year.
NEW YORK - Canadian innovator CarbonCure Technologies has been named one of ten finalists in the global $20 million NRG COSIA Carbon XPRIZE for its technology that profitably converts carbon dioxide (CO2) into stronger and greener concrete. Today’s announcement builds upon the growing industry accolades ...
Innovacorp’s Early Stage Commercialization Fund (ESCF) helps move Nova Scotia university, college and university-affiliated hospital research to market.
Harbr, a mobile job site reporting app that provides predictive scheduling and intelligence for construction, has closed an oversubscribed Seed round of C$1.75 million. This round brings together notable real-estate and construction executives from across North America, giving Harbr access to major markets in the U.S. and Canada.
Legado Capital (Legado) is pleased to announce the successful closing of the acquisition of Kivuto Solutions Inc. (Kivuto), along with a group of investors, including the lead investor, Roynat Equity Partners. (Innovacorp was a founding investor in Kivuto, then e-Academy.)
Update: CheckIn won Shift Challenge, receiving $20,000 and business guidance to put their idea into action. Paraglide won the audience choice award, receiving $5,000.
We received 26 Shift Challenge submissions. A judging committee selected a shortlist of applicants to move on in the challenge.
Breast imaging analytics innovator Densitas Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its machine learning breast density assessment software. The software empowers radiologists with standardized, personalized and automated density reports to optimize women’s breast health and follow-up care decisions.
University of Manchester Research Finds Densitas’ Breast Density Software Demonstrates a Strong Association with Breast Cancer Risk
Densitas Enters Australian Market with Machine Learning Technology for Breast Health
Densitas Inc. announced today that it has received regulatory clearance for its automated breast density software, DM-Density. DM-Density has received regulatory clearance from the Australian Therapeutic Goods Administration (TGA) and will be available through the EnvoyAI Platform.